期刊文献+

Analysis of new drug registration and review in China in 2021

原文传递
导出
摘要 In recent years,China's pharmaceutical industry has undergone tremendous changes.The reform of pharmaceutical policies has led to a shift in the direction of drug research and development from generic to innovative,and the sustainable investment from the capital market into the pharmaceutical industry and the return of overseas pharmaceutical talents have together created a boom in drug research and development in China today.
机构地区 Pharmcube(Beijing)Co.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第4期2127-2128,共2页 药学学报(英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部